Jack A. Khattar is CEO & President at SUPERNUS PHARMACEUTICALS, INC. (SUPN). They have made 16 open-market trades across 2 companies since 2012, most recently 2026-08-12.
CIK 0001539937
3 open-market purchases totalling $296K since 2012, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SUPN | 1,258,351 | $47.7M |
| CGTX | 73,500 | $54K |
| SCPH | 5,000 | $28K |
| Total | $47.7M |
Shares reported on the most recent Form 4, priced at the 2026-08-14 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SUPN | SELL | 2026-03-13 | 2026-03-16 | $50.37 | $1.8M | +1.3% | -0.4% | -12.6% |
| SUPN | SELL · 10b5-1 | 2025-10-09 | 2025-10-10 | $50.57 | $6.1M | +3.0% | -7.7% | +4.0% |
| SUPN | SELL · 10b5-1 | 2025-10-02 | 2025-10-03 | $48.06 | $183K | +1.9% | +15.2% | +2.3% |
| SUPN | SELL · 10b5-1 | 2025-10-01 | 2025-10-02 | $48.07 | $3.9M | +2.6% | +16.1% | +3.6% |
| SUPN | SELL · 10b5-1 | 2025-09-30 | 2025-10-01 | $48.25 | $414K | +0.9% | +15.0% | +4.1% |
| SUPN | SELL · 10b5-1 | 2025-09-29 | 2025-09-30 | $48.02 | $983K | +2.9% | +18.6% | +7.6% |
| SUPN | SELL · 10b5-1 | 2025-09-23 | 2025-09-24 | $47.23 | $2.8M | +2.9% | +12.5% | +10.1% |
| SUPN | SELL · 10b5-1 | 2025-09-22 | 2025-09-23 | $47.02 | $1.6M | +3.1% | +11.0% | +9.9% |
| SUPN | SELL · 10b5-1 | 2025-09-08 | 2025-09-09 | $46.29 | $585K | +0.1% | +7.6% | +2.5% |
| SUPN | SELL · 10b5-1 | 2025-09-05 | 2025-09-08 | $46.01 | $5.1M | +0.9% | +5.0% | +3.1% |
| SUPN | SELL · 10b5-1 | 2025-08-27 | 2025-08-29 | $45.09 | $2.0M | +3.8% | +5.9% | +1.4% |
| SUPN | SELL · 10b5-1 | 2025-08-25 | 2025-08-27 | $45.00 | $45K | +2.1% | +4.3% | +2.2% |
| SUPN | SELL · 10b5-1 | 2025-08-22 | 2025-08-26 | $45.00 | $68K | +3.9% | +7.0% | +2.4% |
| SUPN | SELL · 10b5-1 | 2025-08-06 | 2025-08-08 | $42.02 | $5.9M | +3.5% | +11.1% | +14.6% |
| SUPN | SELL | 2024-11-08 | 2024-11-12 | $36.29 | $4.5M | -4.5% | -4.7% | -0.0% |
| SUPN | SELL | 2024-11-07 | 2024-11-08 | $36.68 | $4.6M | -2.2% | -0.7% | +5.2% |
| SUPN | SELL | 2023-02-02 | 2023-02-06 | $42.06 | $1.1M | -4.7% | -7.0% | -9.3% |
| SUPN | SELL · 10b5-1 | 2023-02-01 | 2023-02-03 | $42.01 | $13K | -6.9% | -7.3% | -11.9% |
| SUPN | SELL · 10b5-1 | 2023-01-31 | 2023-02-02 | $42.01 | $41K | -7.7% | -8.2% | -11.0% |
| SUPN | SELL | 2023-01-18 | 2023-01-20 | $40.40 | $399K | +2.2% | -4.6% | -8.0% |
| SUPN | SELL | 2023-01-17 | 2023-01-19 | $40.03 | $2.0M | +1.4% | -4.0% | -8.0% |
| SUPN | SELL | 2022-12-20 | 2022-12-22 | $38.11 | $1.2M | +4.0% | +9.8% | -5.7% |
| SUPN | SELL | 2022-11-23 | 2022-11-28 | $35.16 | $942K | +0.2% | +0.7% | +6.9% |
| SUPN | SELL · 10b5-1 | 2022-11-22 | 2022-11-23 | $35.00 | $21K | +2.2% | +7.5% | +11.4% |
| SUPN | SELL · 10b5-1 | 2022-11-21 | 2022-11-22 | $35.01 | $19K | +2.5% | +8.1% | +11.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.